Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831

S. W. Luoh

doi:10.1016/j.breastdis.2014.01.029

Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831

Knight Cancer Institute

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	45-47
Number of pages	3
Journal	Breast Diseases
Volume	25
Issue number	1
DOIs	https://doi.org/10.1016/j.breastdis.2014.01.029
State	Published - 2014

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1016/j.breastdis.2014.01.029

Cite this

@article{cd3862cadc3b4993a688687c88ae6373,

title = "Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831",

author = "Luoh, {S. W.}",

year = "2014",

doi = "10.1016/j.breastdis.2014.01.029",

language = "English (US)",

volume = "25",

pages = "45--47",

journal = "Breast Diseases",

issn = "1043-321X",

publisher = "Academic Press Inc.",

number = "1",

}

TY - JOUR

T1 - Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831

AU - Luoh, S. W.

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84896793841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896793841&partnerID=8YFLogxK

U2 - 10.1016/j.breastdis.2014.01.029

DO - 10.1016/j.breastdis.2014.01.029

M3 - Comment/debate

AN - SCOPUS:84896793841

SN - 1043-321X

VL - 25

SP - 45

EP - 47

JO - Breast Diseases

JF - Breast Diseases

IS - 1

ER -

Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this